Vir Biotechnology, Inc. (VIR)
9.96
-2.16
(-17.82%)
USD |
NASDAQ |
Nov 13, 10:06
Vir Biotechnology Free Cash Flow (Quarterly) : -106.12M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -106.12M |
| June 30, 2026 | 123.29M |
| March 31, 2026 | -132.78M |
| December 31, 2025 | -26.22M |
| September 30, 2025 | -167.89M |
| June 30, 2025 | -122.76M |
| March 31, 2025 | -79.74M |
| December 31, 2024 | -90.04M |
| September 30, 2024 | -173.84M |
| June 30, 2024 | -78.51M |
| March 31, 2024 | -111.26M |
| December 31, 2023 | -109.46M |
| September 30, 2023 | -159.54M |
| June 30, 2023 | -398.70M |
| March 31, 2023 | -132.65M |
| December 31, 2022 | 22.53M |
| Date | Value |
|---|---|
| September 30, 2022 | 98.91M |
| June 30, 2022 | 939.54M |
| March 31, 2022 | 534.25M |
| December 31, 2021 | -5.372M |
| September 30, 2021 | -111.82M |
| June 30, 2021 | 137.98M |
| March 31, 2021 | -90.20M |
| December 31, 2020 | -84.48M |
| September 30, 2020 | -51.32M |
| June 30, 2020 | -11.98M |
| March 31, 2020 | -49.71M |
| December 31, 2019 | -40.44M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -30.57M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Moderna, Inc. | -1.68B |
| Vaxcyte, Inc. | -229.04M |
| Arrowhead Pharmaceuticals, Inc. | -181.32M |
| Oncolytics Biotech, Inc. | -8.066M |
| Sangamo Therapeutics, Inc. | -19.30M |